The current approach to seasonal and pandemic flu is akin to a game of Whack-a-Mole. Scientists do their best to anticipate the most likely culprits from a constantly evolving cast of viral characters, hoping that their efforts will land effectively in the…
As the world is embracing the virtues of non-animal derived meats (i.e., made from either plants or lab-grown, cultured protein), non-comestible items relying heavily on animal agriculture need to be rethought too. In our era, animal-derived products must not only keep human…
The goal of any vaccine is to generate immunity to pathogens, in order to reduce the spread of infectious diseases. A vaccine antigen (a foreign substance, usually a protein, that induces an immune response) is introduced into the body (most often via…
San Francisco, CA – March 31, 2021 EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strains—including all flu pandemics. Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health…
Thanks to Al Gore, Greta Thunberg and myriad unnamed scientists and researchers around the world (who have labored for decades to raise awareness), most global citizens are now aware of climate change, and the catastrophic effect of human behavior on our natural…
As cases of COVID-19 continue to rise, experts are raising alerts regarding the likelihood of the next pandemic, likely originating from a family of zoonotic influenza strains well-positioned for the jump from animals to humans. Similar to the SARS-CoV-2 virus (which causes…
As the world reels from the recent impact of COVID-19, researchers are examining ways that the past can inform current and future pandemic response. The most widely documented historic pandemic is that of the Spanish flu in 1918, and while a different…
San Francisco, CA – February 2021 EnGen Bio is an early stage biotechnology company pioneering a new approach to preventing and treating influenza, with the goal of an effective, easy-to-manufacture, shelf-stable universal flu vaccine that should confer long-term immunity to all Type…
As the world still holds its breath for the widespread rollout of COVID-19 vaccines, the experts studying infectious diseases are already shifting their focus to the prevention of the next pandemic. While this may seem pessimistic to those eager to celebrate the…
Scientists agree that the next flu pandemic is a matter of when, not if. EnGen Bio is developing a therapy and vaccine to provide lifetime immunity to Type A flu.